Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Cutting the red tape: the FDA responds with exclusive interview

Drug shortages in the US have been blamed on red tape and bureaucracy suffocating development, but how have the Food and Drug Administration (FDA) responded? In an exclusive interview, Dr Nicola Davies spoke to the FDA to find out whether increasingly stringent regulations are to blame for the steep rise in US drug shortages during the last decade.

Go Top